“neu REFIX ” potentials in Duchenne Muscular Dystrophy will be presented at MENA Rare Diseases Conference in UAE
19/4/2024
“neu REFIX ” potentials in Duchenne Muscular Dystrophy will be presented at Congress held in UAE
About
GN Corporation
Company Policy
Based on Japan’s excellent medical technology, GN Corporation will disseminate new solutions to the world that span the fields of cell culture, tissue engineering, regenerative medicine, medical devices, medical devices, metadata, databases, artificial intelligence, preventive medicine, and health foods.
We will hold academic exchange meetings to promote exchange between different fields such as clinical medicine, materials, and science, and contribute to the development of regenerative medicine.
Partner companies and facilities
| Japan-In dia BioSciences (P) Ltd | B6, 13, Zakariah Colony III St, Choolaimedu Chennai 600 094, TN, INDIA Tel: +91-44 -23720805, 23720806, 94440-82048 Fax: +91-44 – 24732186 |
|---|---|
| Nichi-in Center for Regenerative Medic ine, Japan-India Regenerative Medicine | III F, LICET, Loyola Campus, Nungambakkam, Chennai 600094, TN, India Tel: +91-44-28174743, +91-44-64549484 Fax: +91-44-24732186 |
Profile
| Company name | GN Corporation Co Ltd |
|---|---|
| Location | 〒400-0866 3-8 Wakamatsu, Kofu Yamanashi, JAPAN TEL. 055-235-7527 FAX. 055-235-7569 Email: info@gncorporation.com |
| Established. | August 2002 |
| Bank | Yamanashi Central Bank, Rakuten Bank |
Research and Patents
| Patent No. 5863089 | Gel film for the treatment of corneal endothelitis cell defects |
|---|---|
| Patent No. 6373241 | How cells are stored |
| Patent No. 6714247 | Urethral stenosis treatment agent and urethral stenosis treatment method |
| Patent No. 6757578 | Method for enhancing the function of immune and blood cells by TGP-containing storage solution and microgravity load |
Invest Japan
latest news
“Nichi Glucan” and “Nichi BRITE” potentials will be presented at an academic conference in Osaka, Japan
19/4/2024
“Nichi Glucan” and “Nichi BRITE” potentials will be presented at an academic conference in Osaka, Japan
Discovery of a safe adjuvant to Duchenne Muscular Dystrophy – A journey of 14 years of passion, pursuits & perseverance.
27/11/2023
A curiosity driven sojourn, across disciplines in science, led to the discovery of a safe adjuvant hidden in a beta glucan giving hope to patients with muscular dystrophy; A story of ZeitenWende all along, blessed with good people, hopefully a modest contribution to humanity by connecting the dots.
